CLINICA 100: Medtech’s Top Players Rake In Over $317 Billion
Executive Summary
The medtech market continues to expand, in spite of operating challenges, but currency headwinds depressed top-line growth for outside-US companies. This year’s Clinica 100 league table
, compiled by IN VIVO’s sister publication, Clinica, lists the world’s top 100 medical devices and diagnostic players based on annual sales for 2013 or their most recent fiscal year, as of October 31, 2014.
You may also be interested in...
‘A Forever Battle:’ Patent Reform, Launch Prices, And Where Lower Rx Price Advocates Will Go Next
Pharma’s opponents believe passage of the Inflation Reduction Act represents a momentum shift that will make it easier for politicians (even some Republicans) to take on the industry. They’ll need to count on that as they still have a long list of targets ahead on their lower-drug pricing agenda.
Finance Watch: Karuna, Cerevel And Others Benefit From Improving Biotech Sentiment
Good news in the biopharma industry and the US economy gave public drug developers the boost they needed to raise cash, including Karuna’s $750m offering. Private company financings slowed during the second week of August, but Prellis and Vector BioPharma raised venture capital.
Medtronic Recalls Cardiac Defibrillators Due To Reduced Shock Potential
The device giant is recalling Cobalt and Crome defibrillators because they may deliver weaker shocks than intended.